T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Encompass Health
EHC
$12.2B
| $83.3M | 0.02% |
2,782,703
-461,909
| -14% | -$12.8M |
|
602
Match Group
MTCH
$8.56B
| $82.6M | 0.02% |
7,471,437
+1,045,157
| +16% | +$12M |
|
603
Lam Research
LRCX
$422B
| $82.5M | 0.02% |
9,981,840
-2,107,900
| -17% | -$15.3M |
|
604
Dominion Energy
D
$60.3B
| $82.3M | 0.02% |
1,095,275
+25,270
| +2% | +$1.79M |
|
605
Brinker International
EAT
$10.2B
| $82.2M | 0.02% |
1,788,550
+54,049
| +3% | +$2.6M |
|
606
Cencora
COR
$59.2B
| $81.9M | 0.02% |
946,140
-1,908,425
| -67% | -$170M |
|
|
BRFS
607
DELISTED
BRF SA
BRFS
| $81.8M | 0.02% |
+5,750,603
| New | +$76.1M |
|
|
LABL
608
DELISTED
Multi-Color Corp
LABL
| $81.7M | 0.02% |
1,530,796
+49,620
| +3% | +$2.65M |
|
609
Red Robin
RRGB
$183M
| $81.1M | 0.02% |
1,258,603
+6,240
| +0.5% | +$389K |
|
610
Alnylam Pharmaceuticals
ALNY
$30.4B
| $80.6M | 0.02% |
1,284,082
+46,237
| +4% | +$3.07M |
|
|
MJN
611
DELISTED
Mead Johnson Nutrition Company
MJN
| $80.5M | 0.02% |
947,265
+357,998
| +61% | +$26.6M |
|
|
ENDP
612
DELISTED
Endo International plc
ENDP
| $80.3M | 0.02% |
2,850,793
+1,446,976
| +103% | +$68.3M |
|
613
Sempra
SRE
$56.5B
| $80.1M | 0.02% |
1,540,370
+569,610
| +59% | +$27.4M |
|
614
Chesapeake Utilities
CPK
$3.26B
| $79.9M | 0.02% |
1,268,272
-14,010
| -1% | -$851K |
|
615
TD Synnex
SNX
$20.4B
| $79.3M | 0.02% |
1,712,364
+18,260
| +1% | +$815K |
|
616
Ally Financial
ALLY
$13.6B
| $79.1M | 0.02% |
4,223,107
-4,442,868
| -51% | -$76.6M |
|
617
Bloomin' Brands
BLMN
$924M
| $78.8M | 0.02% |
4,672,646
+584,779
| +14% | +$9.84M |
|
618
Avient
AVNT
$4.23B
| $78.7M | 0.02% |
2,603,095
-144,205
| -5% | -$3.96M |
|
619
Kroger
KR
$35.1B
| $78.5M | 0.02% |
2,051,168
+188,095
| +10% | +$7.26M |
|
|
RAI
620
DELISTED
Reynolds American Inc
RAI
| $77.8M | 0.02% |
1,546,886
+62,690
| +4% | +$3.08M |
|
|
XLRN
621
DELISTED
Acceleron Pharma
XLRN
| $77.8M | 0.02% |
2,947,139
+17,660
| +0.6% | +$514K |
|
|
ALOG
622
DELISTED
Analogic Corp
ALOG
| $77.7M | 0.02% |
983,857
-7,200
| -0.7% | -$539K |
|
623
RE/MAX Holdings
RMAX
$265M
| $77.7M | 0.02% |
2,264,861
+152,210
| +7% | +$5.12M |
|
624
LivaNova
LIVN
$4.53B
| $77.5M | 0.02% |
1,435,339
+1,255,683
| +699% | +$69.8M |
|
|
CBF
625
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $77.5M | 0.02% |
2,510,670
+30,380
| +1% | +$907K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.